304 related articles for article (PubMed ID: 9593418)
1. Beta-agonist therapy and asthma mortality in Japan.
Beasley R; Nishima S; Pearce N; Crane J
Lancet; 1998 May; 351(9113):1406-7. PubMed ID: 9593418
[No Abstract] [Full Text] [Related]
2. Evidence based answers--is salmeterol safe in asthma?
Spurling G; Doust J
Aust Fam Physician; 2006 Aug; 35(8):625-6. PubMed ID: 16894440
[No Abstract] [Full Text] [Related]
3. Present state of the controversy about regular inhaled beta-agonists in asthma.
Giuntini CG; Paggiaro PL
Eur Respir J; 1995 May; 8(5):673-8. PubMed ID: 7656934
[No Abstract] [Full Text] [Related]
4. [Increased asthma fatality in chronic administration of beta agonists?].
Geisler LS
Dtsch Med Wochenschr; 1993 Feb; 118(6):206-7. PubMed ID: 8094666
[No Abstract] [Full Text] [Related]
5. [Asthma and inhalation therapy: the points of view of the patient and the therapist].
Huchon G
Allerg Immunol (Paris); 1993 Oct; 25(8):354-8. PubMed ID: 7903537
[No Abstract] [Full Text] [Related]
6. Is the routine use of inhaled beta-adrenergic agonists appropriate in asthma treatment? Yes.
Wanner A
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):597-9. PubMed ID: 7881643
[No Abstract] [Full Text] [Related]
7. Is the routine use of inhaled beta-adrenergic agonists appropriate in asthma treatment? No.
Sears MR
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):600-1. PubMed ID: 7881644
[No Abstract] [Full Text] [Related]
8. The beta-agonist controversy. Impact in COPD.
Ziment I
Chest; 1995 May; 107(5 Suppl):198S-205S. PubMed ID: 7743827
[No Abstract] [Full Text] [Related]
9. Epidemiologic studies of beta agonists and asthma deaths.
Pearce N; Hensley MJ
Epidemiol Rev; 1998; 20(2):173-86. PubMed ID: 9919437
[No Abstract] [Full Text] [Related]
10. [Side effects of sympathomimetic drugs in patients with bronchial asthma].
Sil'vestrov VP; Bakulin MP
Klin Med (Mosk); 1983 Mar; 61(3):76-8. PubMed ID: 6133979
[No Abstract] [Full Text] [Related]
11. New developments in bronchodilator therapy.
Nelson HS
Curr Opin Pulm Med; 1996 Jan; 2(1):35-9. PubMed ID: 9363113
[TBL] [Abstract][Full Text] [Related]
12. International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992.
Lanes SF; Birmann B; Raiford D; Walker AM
J Clin Epidemiol; 1997 Mar; 50(3):321-8. PubMed ID: 9120532
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of asthma using bronchodilator agents--special reference to adrenergic beta 2-receptor agonists].
Kurosawa M; Igarashi Y; Miyachi Y
Nihon Naika Gakkai Zasshi; 1996 Feb; 85(2):210-5. PubMed ID: 8708449
[No Abstract] [Full Text] [Related]
14. Asthma deaths in New Zealand: whodunnit?
Blauw GJ; Westendorp RG
Lancet; 1995 Jan; 345(8941):2-3. PubMed ID: 7799701
[No Abstract] [Full Text] [Related]
15. [A new long-acting asthma spray. Preliminary wait-and-see attitude?].
Flaten O
Tidsskr Nor Laegeforen; 1993 May; 113(13):1610. PubMed ID: 8101664
[No Abstract] [Full Text] [Related]
16. Risk of severe life threatening asthma.
Barnes NC; Kuitert LM
Thorax; 1996 Nov; 51(11):1073. PubMed ID: 8958886
[No Abstract] [Full Text] [Related]
17. Fenoterol and asthma mortality.
Kremer G; Disse B
Lancet; 1998 Aug; 352(9126):485-6. PubMed ID: 9708779
[No Abstract] [Full Text] [Related]
18. Optical illusions from visual data analysis: example of the New Zealand asthma mortality epidemic.
Suissa S; Ernst P
J Clin Epidemiol; 1997 Oct; 50(10):1079-88. PubMed ID: 9368515
[TBL] [Abstract][Full Text] [Related]
19. New beta 2-adrenergic agonist aerosols.
Kelly HW
Clin Pharm; 1985; 4(4):393-403. PubMed ID: 2864159
[TBL] [Abstract][Full Text] [Related]
20. [Confusing about asthma therapy].
Larsson K; Svedmyr N
Lakartidningen; 1993 Oct; 90(40):3414-5. PubMed ID: 7901463
[No Abstract] [Full Text] [Related]
[Next] [New Search]
